•Insomnia is common in patients with cancer, with a higher prevalence than observed in the general population.•Insomnia is often under-recognised and inadequately treated in patients with cancer.•Brief validated screening tools are available for the evaluation of insomnia in clinical practice.•First-line therapy should be based on international guidelines recommending cognitive behavioural therapy for insomnia.
List of Contributors, vii Foreword, xi Acknowledgements, xiii Part 1 Clinical Issues 1 Introducing Multicultural Psycho-oncology, 3 Luigi Grassi and Michelle Riba 2 Communication in Cancer Care: A Cultural Perspective, 11 Phyllis Butow and Walter F. Baile 3 Psychosocial Assessment and Screening in Psycho-oncology, 21 Paul B. Jacobsen and Kristine A. Donovan 4 Sexuality and Gender: Psychosocial Implications in Cancer Patients: A Multicultural Perspective, 39 Anna Costantini, Chiara M. Navarra, Kimlin Tam Ashing-Giwa and Sophia Yeung 5 Psychosocial and Psychiatric Disorders, 55 Santosh K. Chaturvedi and Yosuke Uchitomi 6 Neurocognitive Effects of Anticancer Treatments, 71 Tim Ahles, Sanne Schagen and Janette Vardy 7 Screening for Distress, the 6th Vital Sign, as the Connective Tissue of Health Care Systems: A Roadmap to Integrated Interdisciplinary Person-centred Care, 83 Barry D. Bultz, Matthew J. Loscalzo and Karen L. Clark 8 Psychological Intervention, 97 Maggie Watson 9 Psychopharmacological Interventions, 109 Seema M. Thekdi, Marya Elisa Irarrazaval and Laura B. Dunn 10 Rehabilitation, 127 Anja Mehnert and Uwe Koch Part 2 Special Populations 11 Pediatric Psycho-oncology, 139 Margaret L. Stuber and Elizabeth M. Strom 12 A Life-stage Approach to Psycho-oncology, 155 Peter Fitzgerald, Rinat Nissim and Gary Rodin 13 Psycho-oncology in Underserved and Minority Populations, 165 Richard Fielding and Wendy W.T. Lam Part 3 Other Topics 14 Exploration of Family Care: A Multicultural Approach, 187 Lea Baider and Gil Goldzweig 15 Bioethical Challenges: Understanding Cultural Differences and Reducing Health Disparities, 199 Antonella Surbone 16 Post-traumatic Growth in Cancer Patients Across Cultures, 211 Michael Diaz, Matthew Cordova and David Spiegel 17 The Need for Psychosocial Support in Genetic Counselling and Genetic Testing, 223 Mary Jane Esplen, Jonathan Hunter and Kathryn M. Kash 18 Psychosocial and Physical Health in Post-treatment and Extended Cancer Survivorship, 237 Patricia A. Ganz and Annette L. Stanton 19 End-of-life Care, 249 William Breitbart, Harvey Max Chochinov and Yesne Alici 20 Grief and Bereavement, 271 Sue Morris and Susan Block 21 Spiritual and Religious Coping with Cancer, 281 David W. Kissane, Carrie E. Lethborg and Brian Kelly 22 Psycho-oncology and Advocacy in Cancer Care: An International Perspective, 297 Luzia Travado, Jan Geissler, Kim Thiboldeaux, Jeff Dunn, Ranjit Kaur and Anne Merriman Index, 311
Here, we review the prevalence and treatment of anxiety and depression among patients with breast cancer. Cancer-related symptoms include similarities to responses to traumatic stress. Well-developed screening devices for identifying and tracking psychiatric comorbidity are discussed. Basic principles of psychopharmacology, and individual and group psychotherapy are presented. Finally, effects of effective treatment of anxiety and depression on quality of life and overall survival are reviewed.
